Evidence map›Paper›PMID 40269077›Full record

ArticleScientific reports2025

Levodopa influence on turning dynamics in people with Parkinson's disease.

Lakshmi Pillai, Reid D Landes, Tuhin Virmani

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lakshmi PillaiDepartment of Neurology, University of Arkansas for Medical Sciences, 4301 W. Markham St., #500, Little Rock, AR, 72205-7199, USA.ORCID http://orcid.org/0000-0002-6570-2041
Reid D LandesDepartment of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.ORCID http://orcid.org/0000-0002-6349-0081
Tuhin VirmaniDepartment of Neurology, University of Arkansas for Medical Sciences, 4301 W. Markham St., #500, Little Rock, AR, 72205-7199, USA. TVirmani@uams.edu.ORCID http://orcid.org/0000-0002-1826-2020

Funding

Expanding Translational Research in ArkansasUL1TR003107 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2019 to 2023
$21.6M
Telemedicine CoreP30GM110702 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI GARCIA-RILL, EDGAR E. · 2014 to 2018
$6.1M
NCATS NIH HHS UL1 TR003107NIGMS NIH HHS GM110702NIGMS NIH HHS P30 GM110702Parkinson's Foundation PF-JFA-1935
6 · The paper itself

Abstract

Turning behaviors are affected in people with Parkinson's disease (PwPD) leading to falls and Freezing of Gait (FOG). Levodopa therapy is commonly recommended for PwPD to help alleviate motor symptoms. Knowledge of turning dynamics with levodopa therapy is limited and could improve clinical care. We enrolled 44 PwPD already on levodopa therapy and analyzed their turns on an instrumented gait mat. Participants made 180-degree turns in their OFF-state (> 8 h off levodopa) then ON-state (1 h after levodopa). Thirteen turn measures were assessed for changes between the OFF- to ON-state. Compared to the OFF-state, in the ON-state turns had significantly faster stride-velocity and fewer steps were taken to complete turns. Regression modeling suggested greater improvement in turn stride-velocity with longer levodopa duration while greater FOG severity was associated with taking fewer steps to turn in ON- compared to the OFF-state. Our data suggests worse OFF-state function and retained levodopa responsiveness leading to larger improvement in turn measures, in those on levodopa longer (or longer disease duration), and in those within our cohort experiencing levodopa unresponsive FOG. Our results provide important evidence for continued aggressive levodopa management to improve mobility during turns even in advanced Parkinson's disease.

Indexed as

Antiparkinson AgentsGaitLevodopaParkinson DiseaseAgedFemaleGait Disorders, NeurologicHumansMaleMiddle AgedAntiparkinson AgentsLevodopaDisease progressionFreezing of gaitGait analysisMedication responseObjective measuresTurning in Parkinson’s

Identifiers

PMID40269077
PMCPMC12019590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.